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Successful pathogens have evolved strategies to
interfere with host immune systems. For example,
the ubiquitous plant pathogen Pseudomonas syrin-
gae injects two sequence-distinct effectors, AvrPto
and AvrPtoB, to intercept convergent innate immune
responses stimulated by multiple microbe-associ-
ated molecular patterns (MAMPs). However, the
direct host targets and precise molecular mecha-
nisms of bacterial effectors remain largely obscure.
We show that AvrPto and AvrPtoB bind the Arabi-
dopsis receptor-like kinase BAK1, a shared signaling
partner of both the flagellin receptor FLS2 and the
brassinosteroid receptor BRI1. This targeting inter-
feres with ligand-dependent association of FLS2
with BAK1 during infection. It also impedes BAK1-
dependent host immune responses to diverse other
MAMPs and brassinosteroid signaling. Significantly,
the structural basis of AvrPto-BAK1 interaction
appears to be distinct from AvrPto-Pto association
required for effector-triggered immunity. These
findings uncover a unique strategy of bacterial path-
ogenesis where virulence effectors block signal
transmission through a key common component of
multiple MAMP-receptor complexes.
INTRODUCTION
Plants and animals use pattern-recognition receptors (PRRs) to
detect pathogen- or microbe-associated molecular patterns
(PAMPs or MAMPs) and activate the first line of innate-immune
responses (Akira et al., 2006; Ausubel, 2005; Chisholm et al.,
2006; Jones and Dangl, 2006). The mammalian cell-surface
transmembrane PRRs consist of a limited number of Toll-likereceptors that are critical for perceiving a diverse range of
MAMPs derived from bacteria, fungi, parasites, and viruses
(Akira et al., 2006). Plants appear to have evolved a large number
of PRRs for recognition of a wide array of MAMPs from both
pathogenic and nonpathogenic microbes (He et al., 2007b;
Nu¨rnberger et al., 2004; Shiu and Bleecker, 2003; Zipfel and Fe-
lix, 2005). There are hundreds of receptor-like kinases (RLKs) in
plants (Shiu and Bleecker, 2003), some of which detect MAMPs
and launch cascades of immune responses (Go´mez-Go´mez and
Boller, 2000; Zipfel and Felix, 2005; Zipfel et al., 2006). The well-
characterized MAMP receptors are the flagellin receptor (Flagel-
lin Sensing 2, FLS2) and the elongation factor EF-Tu receptor
(EFR) in Arabidopsis (Go´mez-Go´mez and Boller, 2000; Zipfel
et al., 2006). Affinity-crosslinking assays demonstrated direct
binding of flagellin with FLS2 and EF-Tu with EFR, respectively
(Chinchilla et al., 2006; Zipfel et al., 2006). In addition to their
roles in plant immunity, RLKs are also implicated in plant growth
and development, such as CLV1 (CLAVATA1) in controlling mer-
istem size, BRI1 (brassinosteroid insensitive 1) in perceiving
plant hormone brassinosteroids (BRs), and ERECTA-family
receptors in stomatal patterning (Belkhadir et al., 2006; Clark
et al., 1993; Shpak et al., 2005).
The recognition of different MAMPs by specific PRRs induces
common-signaling pathways involving MAP-kinase activation
and defense-gene transcription (Qutob et al., 2006; Zipfel
et al., 2006). It remains unknown how distinct MAMP perception
activates the convergent immune responses. It has been shown
recently that flagellin could rapidly stimulate the association of
FLS2 with another RLK, BAK1, which was originally identified
as a BRI1-associated receptor kinase mediating BR signaling
(Li et al., 2002; Nam and Li, 2002). However, bak1-mutant plants
did not reduce flagellin binding, suggesting that BAK1 is not
involved in flagellin perception (Chinchilla et al., 2007). Impor-
tantly, BAK1 is likely involved in multiple MAMP responses,
including flagellin, EF-Tu, bacterial cold-shock protein, and
oomycete elicitor INF1 in Arabidopsis and Nicotiana benthami-
ana (Chinchilla et al., 2007; Heese et al., 2007). The bak1-mutant
plants also displayed enhanced susceptibility to someCell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc. 17
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function in distinct receptor-signaling complexes to integrate
multiple MAMP perception into downstream-signaling events.
Successful pathogens have evolved strategies to interfere
with host immune systems. Many Gram-negative bacteria inject
a battery of effector proteins through the type III secretion sys-
tem to promote pathogenesis in plants and animals (Abramo-
vitch et al., 2006; Alfano and Collmer, 2004; Gala´n, 2007; Grant
et al., 2006). Some of these effectors function as enzymes or reg-
ulatory mimics to manipulate diverse host cellular activities es-
sential for innate immunity. For instance, virulence effectors
from plant and animal bacterial pathogens target evolutionarily
conserved MAP-kinase cascade components with different en-
zymatic activities to impede host immunity (Shan et al., 2007).
Two sequence-distinct effectors, AvrPto and AvrPtoB (HopAB2)
from Pseudomonas syringae, have been found to intercept mul-
tiple MAMP-mediated signaling (de Torres et al., 2006; Hann and
Rathjen, 2007; He et al., 2006). Significantly, expression of
AvrPto or AvrPtoB suppresses defense responses and promotes
bacterial proliferation in Arabidopsis and N. benthamiana (de
Torres et al., 2006; Hann and Rathjen, 2007; He et al., 2006). Mo-
lecular analysis suggests that the potent suppression function of
AvrPto and AvrPtoB occurs upstream of MAPKKK (MAP kinase
kinase kinase) in MAP-kinase signaling cascades triggered by
multiple MAMPs (He et al., 2006). However, the direct-host
targets and precise molecular mechanisms underlying the sup-
pression function of AvrPto and AvrPtoB remain obscure.
We have previously proposed that AvrPto and AvrPtoB likely
target multiple RLKs involved in MAMP perception in Arabidop-
sis (He et al., 2006). Alternatively, AvrPto and AvrPtoB may target
a convergent component upstream of MAPKKK in multiple-
MAMP signaling. Our extensive analyses of avrPto-expressing
transgenic plants revealed surprising AvrPto-associated growth
defects not observed in the known MAMP-receptor mutants but
resembling BR-deficient mutants. We discovered that AvrPto
and AvrPtoB target BAK1, a signaling partner of multiple PRRs
in plant immunity and in BR signaling. This targeting leads to
the dissociation of ligand-induced MAMP-receptor complexes,
thereby blocking the initiation of MAMP signaling. Remarkably,
AvrPto and AvrPtoB delivered from pathogenic bacteria are
sufficient to interfere with the bacterial-induced formation of
FLS2-BAK1 receptor-signaling complex in plant leaves. Exten-
sive mutagenesis and deletion analyses of AvrPto and AvrPtoB
supported the biological significance of AvrPto/AvrPtoB-BAK1
interactions in their MAMP-suppression function. Our data also
revealed that the AvrPto/AvrPtoB interaction with BAK1 for
suppressing MAMP signaling in Arabidopsis is likely structurally
distinct from AvrPto/AvrPtoB interaction with Pto kinase for
activating effector-triggered immunity (ETI) in tomato.
RESULTS
The avrPto Transgenic Plants Display
Brassinosteroid-Insensitive Phenotypes
An intriguing observation leading to our discovery of an AvrPto
host target was obtained from the phenotype of transgenic Ara-
bidopsis plants expressing avrPto under the control of a constitu-
tive cauliflower mosaic virus 35S promoter. Multiple transgenic
plants constitutively expressing AvrPto displayed dwarfed stat-18 Cell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc.ure with small, round, and thick leaves; short petioles; reduced
apical dominance; and short inflorescences without viable seeds
(Figures 1A and S1). The unexpected growth defects caused by
AvrPto expression in transgenic Arabidopsis are not observed in
known MAMP-receptor mutants, such as the fls2 or efr mutants
(Go´mez-Go´mez and Boller, 2000; Zipfel et al., 2006), suggesting
that the potential AvrPto host targets may not be limited to the
proposed PRRs in plant innate immunity (He et al., 2006).
The 35S::avrPto transgenic plants resembled weak bri1 mu-
tants that are insensitive to BRs, the plant hormone with roles
in division, expansion, and differentiation of cells and reproduc-
tive development (Belkhadir et al., 2006). BRs have also been
implicated to play a role in plant resistance to a wide range of
pathogens (Nakashita et al., 2003). Pathogens may potentially
manipulate BR biosynthesis or signaling to promote pathogenic-
ity. Furthermore, three independent transgenic lines with dexa-
methasone (DEX)-inducible AvrPto expression displayed the
open-cotyledon phenotype in dark-grown seedlings as found
in BR biosynthesis and signaling mutants, such as the det2
(de-etiolated2), bri1, and bak1 (bri1-associated receptor kinase1)
(Figures 1B and S2) (Belkhadir et al., 2006; Li et al., 2002; Nam
and Li, 2002). Importantly, inducible AvrPto expression caused
moderate but statistically significant alteration of BR-responsive
gene activation (SAUR-AC and IAA5) and repression (CPD) con-
trolled by brassinolide (BL) (Figure 1C). The control plants with-
out DEX or BL treatment did not exhibit gene-expression
changes (data not shown). AvrPto did not affect the plant re-
sponse to another growth-promoting hormone auxin (Chen
et al., 2007) (Figure S3), suggesting that AvrPto expression did
not alter general hormone effects in plants. The results indicated
that AvrPto specifically diminished BR signaling.
AvrPto and AvrPtoB Interact with BAK1
Plasma-membrane localization is essential for the AvrPto action
in suppressing MAMP signaling in plants (He et al., 2006). We
therefore hypothesized that AvrPto might directly interact and in-
terfere with the functions of the BR receptor BRI1 and/or its as-
sociated receptor-like kinase BAK1. Using a yeast split-ubiquitin
assay designed for membrane proteins (Obrdlik et al., 2004), we
found that AvrPto interacted with BAK1 but not BRI1 in the yeast
(Figure 1D). Furthermore, an AvrPto mutant (AvrPtoS46P) that is
unable to suppress MAMP signaling (He et al., 2006) no longer
interacted with BAK1 (Figure 1D). Although it has recently been
shown that AvrPto associated with FLS2 in plant cells (Xiang
et al., 2008), the interaction of AvrPto and FLS2 was not detected
in the yeast split-ubiquitin assay, and the AvrPto-BAK1 interac-
tion does not require FLS2 or other PRRs (Figure 1D).
We further examined the in vivo interaction of epitope-tagged
AvrPto and BAK1 using coimmunoprecipitation (coIP) assay.
AvrPto interacted strongly with BAK1 independent of the FLS2
ligand flg22 (a 22 amino acid synthetic-peptide elicitor derived
from bacterial flagellin) (Figure 2A). AvrPto also interacted with
BAK1 in the fls2 mutant, indicating that this interaction is inde-
pendent of FLS2 (data not shown). Consistent with the yeast
split-ubiquitin assay results (Figure 1D), AvrPtoS46P and
AvrPtoY89D, which do not suppress MAMP signaling, displayed
significantly reduced affinity to BAK1 in the CoIP assay (Figures
2A and S4A). AvrPtoS147R, which has suppression activity (He
et al., 2006), still interacted with BAK1 (Figure S4A). AvrPtoB,
Cell Host & Microbe
Bacterial Effectors Target BAK1 for PathogenicityFigure 1. The avrPto-Transgenic Plants Display Brassinosteroid-Insensitive Phenotypes
(A) Transgenic Arabidopsis plants expressing 35S::avrPto show similar growth phenotypes as the weak brassinosteroid-insensitive mutant bri1-119. The plants
were grown in the soil under the 12 hr light cycle in a growth chamber. The 4-week-old plants are shown.
(B) The DEX-inducible avrPto transgenic (1, 2, and 3), bak1- (1–3 and 1–4), and det2-mutant seedlings exhibit open cotyledons in the dark. Seedlings were grown
in the dark for 7 days with or without 10 mM DEX.
(C) Altered gene expression in avrPto-transgenic plants. Seedlings were pretreated with 10 mM DEX for 24 hr before treatment with 0.1 mM BL or control (DMSO)
for 3 hr. The data are shown as means ± standard errors from three independent biological replicates. * indicates a significant difference with p < 0.05 when
compared with data from wild-type (WT) based on the results of an unpaired Student’s t test.
(D) AvrPto interacts with BAK1, but not FLS2 or BRI1, in a yeast split-ubiquitin assay. NubWT is wild-type N-terminal ubiquitin half (Nub) as a positive control. pNX
and pMet are empty vectors with N- or C-terminal mutated-ubiquitin half as negative controls. S46P is a mutant of AvrPto without MAMP-suppression activity.
The experiments were repeated three times with similar results.a sequence-distinct effector exhibiting similar MAMP-suppres-
sion activity as AvrPto (He et al., 2006), also associated with
BAK1 in vivo (Figure 2A). The N-terminal 387 amino acids of
AvrPtoB are required and sufficient to block MAMP signaling
(Xiao et al., 2007). Significantly, AvrPtoB1–387—but not
AvrPtoB1–307 or AvrPtoB308–553, which could not suppress
flg22 signaling (Figure S6C)—associated with BAK1 in vivo
(Figure 2B). AvrRpt2, an effector protein with a virulence function
distinct from that of AvrPto and AvrPtoB (Chen et al., 2007; He
et al., 2006), did not coimmunoprecipitate with BAK1, confirming
the specificity and functional link of the BAK1 interaction with
AvrPto and AvrPtoB.
Although we did not detect the interaction of AvrPto with FLS2
in the yeast assay (Figure 1D), AvrPto did associate with FLS2 in-
dependent of flg22 in vivo in the coIP assay (Figure S5A), perhaps
due to higher protein expression. Significantly, the AvrPtoS46P,
which lacks MAMP-suppression activity, still coimmunoprecipi-
tated with FLS2 (Figure S6A). Moreover, two AvrPtoB-deletion
mutants (AvrPtoB1–307 and AvrPtoB308–553) that do not suppress
MAMP signaling (Xiao et al., 2007) (Figure S6C) did not associate
with BAK1 (Figure 2B) but still associated with FLS2 (Figure S6B).
These observations suggest that the association of AvrPto or
AvrPtoB with FLS2 is distinct from that with BAK1 and may not
be functionally relevant to the suppression of MAMP signaling.To examine possible differential affinities and reveal possible
artifacts arising from protein overexpression, we coexpressed
BAK1 and FLS2 at similar amounts with reduced AvrPto-expres-
sion levels in the same plant cells. AvrPto specifically coimmuno-
precipitated with BAK1 but not with FLS2 (Figure 2C), suggesting
that AvrPto has higher affinity to BAK1 than FLS2 in vivo. Finally,
we also observed that AvrPto could weakly coimmunoprecipitate
with EFR and the highly overexpressed chitin receptor CERK1
(Figure S5B) (Miya et al., 2007; Zipfel et al., 2006), but not CLV1,
BRI1, or a putative LysM receptor-like kinase At2g23770, a close
homolog of CERK1 (Figures S5C and S6A). However, protein
association does not necessarily correlate with functional sign-
ificance as observed for AvrPto/AvrPtoB-FLS2 interactions
(Figure S6).
AvrPto Disrupts Flagellin-Induced FLS2-BAK1
Complex Formation
Recent findings have shown that BAK1 associates with FLS2
only after flg22 perception and that BAK1 is critical for flagel-
lin-induced signaling (Chinchilla et al., 2007; Heese et al.,
2007). To investigate the biological significance of the AvrPto-
BAK1 interaction, we tested flg22-induced FLS2-BAK1 associa-
tion in the presence or absence of AvrPto. As shown in Figure 3A,
AvrPto effectively diminished FLS2-BAK1 association activatedCell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc. 19
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Bacterial Effectors Target BAK1 for PathogenicityFigure 2. AvrPto and AvrPtoB Associate with BAK1 In Vivo
(A) AvrPto and AvrPtoB associate with BAK1 in vivo independent of flg22. CoIP was performed with protoplasts coexpressing BAK1-FLAG and different HA-
tagged effector proteins. S46P is an AvrPto mutant. The coIP was carried out with anti-HA-agarose (IP: a-HA), and the proteins were analyzed using western
blot analysis with an anti-FLAG antibody (WB: a-FLAG). The top panel shows coIP results, and the middle and bottom panels show protein expression. Proto-
plasts were treated with 1 mM flg22 for 5 min.
(B) AvrPtoB deletion mutants, which lack MAMP-suppression activity, do not associate with BAK1. The coIP was performed with protoplasts coexpressing
BAK1-FLAG and HA-tagged full-length AvrPtoB1–553 or AvrPtoB-deletion mutants.
(C) AvrPto has higher affinity to BAK1 than FLS2 in vivo. Moderate amounts of BAK1-HA, FLS2-HA, and AvrPto-FLAG were coexpressed in protoplasts. The
above experiments were repeated three times with similar results.by flg22. AvrPtoB also caused a similar effect, indicating at least
one shared molecular mechanism for these two distinct viru-
lence effectors in blocking MAMP signaling (Figure 3A). The in-
terception of MAMP signaling by AvrPto likely occurred at the
plasma membrane since the AvrPtoG2A protein, which no longer
associates with the plasma membrane and lacks the suppres-
sion activity (He et al., 2006), lost the ability to interfere with the
FLS2-BAK1 association induced by flg22 (Figure 3A). The
AvrPtoS46P mutant with low-binding affinity for BAK1 also did
not interfere with the FLS2-BAK1 association triggered by
flg22 (Figure 3A), reinforcing the functional importance of the
AvrPto-BAK1 interaction. As a negative control, a distinct viru-
lence effector HopD2 (also known as HopPtoD2 and HopAO1)
was not effective in interrupting the FLS2-BAK1 association trig-
gered by flg22 (Figure 3A).20 Cell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc.To demonstrate the physiological significance of AvrPto action
in planta and to avoid protein overexpression, we generated
transgenic plants expressing both functional BAK1-GFP at the
endogenous level (Nam and Li, 2002) and DEX-inducible
AvrPto-HA (He et al., 2006). Consistent with the cell-based as-
says, the association of endogenous FLS2 with BAK1-GFP was
completely blocked by AvrPto (Figure 3B). To further control for
possible effector protein overexpression artifacts, we examined
the ability of bacterial-delivered type III effectors to disrupt the
FLS2 and BAK1 complex formation activated by bacterial inocu-
lation in Arabidopsis plants. The FLS2 and BAK1 association
could be equally stimulated by P. s. tomato DC3000 and its
type III secretion mutant hrcC 0.5 hr postinoculation (hpi)
(Figure 3C). This is likely due to the presence of MAMP signals, es-
pecially flagellin in the bacteria. At 2 hpi, the FLS2 and BAK1Figure 3. AvrPto Interferes with FLS2-BAK1 Association
(A) AvrPto and AvrPtoB suppress FLS2-BAK1 association stimulated by flg22 in protoplasts. CoIP was performed with protoplasts coexpressing BAK1-FLAG,
FLS2-HA, and different GFP-tagged effector proteins. Protoplasts were treated with 1 mM flg22 for 5 min. G2A and S46P are two mutants of AvrPto.
(B) AvrPto abolishes FLS2-BAK1 association triggered by flg22 in seedlings.BAK1::BAK1-GFP-transgenic seedlings with or without the DEX inducible avrPto-HA
transgene were treated with 10 mM DEX for 24 hr and stimulated with 1 mM flg22 for 5 min. The coIP was carried out with an anti-GFP antibody (IP: a-GFP), and the
proteins were collected with protein G-agarose and analyzed using western blot with an anti-FLS2 antibody (WB: a-FLS2).
(C) AvrPto and AvrPtoB delivered by DC3000 interfere with FLS2-BAK1 association. BAK1::BAK1-GFP- transgenic plants were inoculated with different DC3000
strains for coIP assay. The experiments were repeated three times with similar results.
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Bacterial Effectors Target BAK1 for PathogenicityFigure 4. Interaction of BAK1-Deletion Mutants with AvrPto
(A) Schematic diagram of BAK1 and its deletion mutants. BAK1 contains an extracellular domain, a transmembrane domain (TM), an intracellular-juxtamembrane
domain (J), and a kinase domain. The amino acid positions of each domain are indicated.
(B) TM, J, and kinase domain of BAK1 are required for association with AvrPto in vivo. The coIP was performed with protoplasts coexpressing FLAG-tagged
BAK1-deletion mutants with or without AvrPto-HA.
(C) AvrPto interacts with BAK1TJK in a yeast split-ubiquitin assay. NubWT is a positive control. pNX and pMet are empty vectors.
(D) BAK1 kinase domain does not interact with AvrPto in a yeast two-hybrid assay. All the experiments were repeated three times with similar results.association was reduced in plants inoculated with the virulent
strain DC3000, but was enhanced further by hrcC, suggesting
that effectors secreted from DC3000 have the ability to interfere
with FLS2 and BAK1 association (Figure 3C). Most significantly,
plants inoculated with aDavrPtoDavrPtoBdouble mutant showed
increased association between FLS2 and BAK1 as compared
with DC3000-inoculated plants (Figure 3C). These data indicate
that, when delivered by P. s. tomato at natural levels, AvrPto
and AvrPtoB are able to suppress bacterial-induced FLS2 and
BAK1 association and downstream signaling in intact plants.
The interaction between AvrPto and BAK1 also reduced the as-
sociation between BRI1 and BAK1 in the presence or absence of
BL (Figure S7A), consistent with the BR-insensitive phenotypes
observed in avrPto-transgenic plants (Figures 1, S1, and S2). In
this case, it appears the AvrPto interaction with BAK1 was suffi-
cient to disrupt the BRI1-BAK1 complex since AvrPto did not
directly interact with the receptor BRI1 (Figures 1D and S6A).
These results suggested that AvrPto physically interferes with
the formation of stable receptor complexes, FLS2-BAK1 and
BRI1-BAK1, critical for distinct signaling pathways triggered by
specific ligands, thereby contributing to its virulence function
and to its effect on BR signaling in plant growth and development.
BAK1’s Transmembrane and Kinase Domains
Are Essential for Its Interaction with AvrPto
BAK1 encodes an RLK with a putative extracellular domain,
a single transmembrane domain, an intracellular-juxtamem-brane domain, and a kinase domain (Li et al., 2002; Nam and
Li, 2002) (Figure 4A). To determine which domains of BAK1 inter-
act with AvrPto, we generated different deletions of BAK1 and
tested their interaction with AvrPto in plant cells and in yeast.
BAK1 without kinase domain (ETJ) did not coimmunoprecipitate
with AvrPto from plant cells (Figure 4B) and did not interact with
AvrPto in the yeast split-ubiquitin assay (Figure 4C). However,
BAK1-kinase domain alone is not sufficient to interact with
AvrPto in the coIP assay (Figure 4B) or in a conventional yeast
two-hybrid assay (Figure 4D). BAK1-kinase domain with juxta-
membrane and transmembrane domains strongly coimmuno-
precipitated with AvrPto in vivo (Figure 4B) and interacted with
AvrPto in a yeast split-ubiquitin assay (Figure 4C), suggesting
that BAK1-transmembrane domain is essential for its interaction
with AvrPto. The data are consistent with the observation that
AvrPto functions inside plant cells, and its plasma membrane
localization is critical to suppress MAMP signaling.
AvrPto/AvrPtoB Interaction with BAK1
Is Distinct from that with Pto
In certain tomato genotypes, Pto-protein kinase recognizes
AvrPto to initiate effector-triggered immunity (ETI) mediated by
the NB-LRR (nucleotide-binding-leucine-rich-repeat) protein
Prf (Pedley and Martin, 2003). Recent crystal-structure analysis
has identified key contact residues in two interfaces of Pto,
H49/V51/F52 and T204, for AvrPto interaction (Xing et al.,
2007). We aligned the Pto sequence with the kinase domainsCell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc. 21
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AvrPto and FLS2
(A) Association of BAK1 mutants with AvrPto.
F300A and T455N are two mutants of BAK1.
BAK1(F300) is the equivalent of Pto(F52) in the first
interaction interface for AvrPto, and BAK1(T455) is
the equivalent of Pto(T204) in the second interface.
(B) Association of BAK1 mutants with FLS2 acti-
vated by flg22. The experiments were repeated
three times with similar results.of BAK1 and other receptor kinases, including SERK4, SERK5,
FLS2, EFR, BRI1, CLV1, ERECTA, CERK1, and At2g23770
(Figure S8). The overall sequence similarity of these receptor
kinases is not correlated with their differential binding affinity to
AvrPto (Figure S8B).
There is no significant sequence conservation in the first inter-
face of AvrPto-Pto interaction among these receptor kinases as
the critical residues, Pto(H49) and Pto(V51), are both absent
(Xing et al., 2007). Pto(F52), which makes van der Waals contact
with AvrPto (Xing et al., 2007), is relatively conserved among
them (Figure S8A). However, the BAK1F300A mutation did not
affect its interaction with AvrPto in the coIP assay (Figure 5A)
and the yeast split-ubiquitin assay (data not shown). The second
interface for AvrPto-Pto interaction is relatively conserved. The
residue T204 in Pto that determines the specific recognition of
AvrPto (Xing et al., 2007) is present in most receptor kinases
except CLV1 (Figure S8A). However, unlike PtoT204N, the
BAK1T455N mutation did not compromise its interaction with
AvrPto (Figure 5A). The same BAK1F300A and BAK1T455N muta-
tions also did not affect the association of BAK1 with FLS2
induced by flg22 (Figure 5B). Finally, AvrPtoB1–307, which is suf-
ficient to interact with Pto and trigger ETI in tomato but lacks the
MAMP-suppression activity (Xiao et al., 2007), did not interact
with BAK1 in Arabidopsis (Figures 2B and S6C). Our results
therefore suggest that structural aspects of the AvrPto/AvrPtoB
interaction with BAK1 for suppressing MAMP signaling are dif-
ferent from those involved in the interaction of these effectors
with Pto for activating ETI.
The crystal structure of the AvrPto-Pto complex and an in vitro
kinase assay suggested that AvrPto may function as a kinase
inhibitor (Xing et al., 2007). However, AvrPto activation of ETI sig-
naling is independent of its kinase-inhibition activity on the Pto
kinase (Xing et al., 2007). AvrPto did not affect BL-enhanced
BAK1 and BRI1 phosphorylation at least as detected by an
anti-Thr-P antibody in plant cells (Figure S7B). It remains possi-
ble that AvrPto interferes with other specific phosphorylated res-
idues (e.g., Ser) on BAK1. Limited by the availability of anti-Ser/
Thr-P antibody and a lack of information on flg22-mediated FLS2
phosphorylation, we were unable to detect in vivo phosphory-
lated FLS2 or BAK1 triggered by flg22 using the same assay
despite extensive efforts. An in vitro kinase assay of FLS2 and
BAK1 was not feasible since FLS2 and BAK1 association cannot
be triggered by flg22 in vitro (Chinchilla et al., 2007).
BAK1 Is Involved in Multiple MAMP Signaling
We have shown that AvrPto is able to block immune signaling
triggered by individual MAMPs and by the hrcC mutant without
a functional type III secretion system (He et al., 2006). To further
connect the physiological function of a host target to the viru-22 Cell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc.lence function of AvrPto, we examined the importance of BAK1
in MAMP signaling in intact plants inoculated with hrcC-mutant
bacteria. Three independent loss-of-function bak1 mutants in
the Col-0 (bak1-3 and bak1-4) and Ws background (bak1-1) dis-
played reduced early marker gene response activated by the
hrcC mutant (Figure 6A). The induction of early MAMP marker
genes by the hrcC mutant was likely due to the presence of mul-
tiple MAMPs from the bacteria as the lack of the FLS2 receptor in
the Col-0 fls2 mutant and Ws (also an fls2 mutant) did not signif-
icantly affect the responses (Figure 6A). The reduced response in
bak1 mutants suggested that BAK1 could be a shared-signaling
partner for other MAMPs besides flagellin.
Analyses of responses to more individual MAMPs in isolated
leaf cells and in whole seedlings supported the important role
of BAK1 in flg22, elf18, HrpZ, peptidoglycan (PGN), and lipopoly-
saccharide (LPS) but not in chitin or NPP1 signaling (Figures 6B
and S9). These results suggest that BAK1 functions in many but
not all MAMP-signaling responses. Interestingly, AvrPto could
be equally effective in suppressing the immune responses trig-
gered by all these MAMPs (Figure 6C) (He et al., 2006). Thus,
AvrPto might target other receptor-signaling complexes in addi-
tion to the ones involving BAK1 or other unknown MAMP-signal-
ing components. In the bak1mutant, the reduction of flg22, elf18,
HrpZ, PGN, and LPS responses was partial but statistically signif-
icant (Figures 6B and S9), suggesting the presence of additional
host targets for AvrPto providing redundant functions to BAK1.
CoIP analysis indicated that the closest BAK1 homologs,
BKK1 (SERK4) and SERK5, could also form complexes with
AvrPto and provide partially overlapping activity in the MAMP-
and BR-signaling pathways (Figure S10) (He et al., 2007a). A
recent study has showed that the bak1 bkk1 double mutant is
seedling lethal, and BAK1 and BKK1 play independent roles in
BR signaling and in the suppression of cell death (He et al.,
2007a). The seedling lethality of the double mutant precluded
the examination of its responses to MAMPs and pathogen infec-
tions. We carried out quantitative pathogen-infection assays in
the bak1-mutant plants pretreated with flg22. Correlated with
their partial reduction of the early marker gene activation in
bak1 (Figures 6A, 6B, and S9), the resistance to DC3000 infec-
tion induced by flg22 was reduced in the bak1-mutant lines
(Figure S11). Together, our data suggest that BAK1 is involved
in diverse MAMP signaling and that a single effector protein
can target BAK1 in multiple host receptor-signaling complexes
to maximize its virulence functions.
DISCUSSION
Lacking specialized immune cells and adaptive immunity, plants
have evolved large numbers of potential PRRs to recognize
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discovered as a key component in MAMP signaling in Arabidop-
sis and tobacco (Chinchilla et al., 2007; Heese et al., 2007).
We report here that bacterial virulence effectors, AvrPto and
Figure 6. BAK1 Is Important in Multiple MAMP-Signaling Pathways
(A) Three bak1 mutants are impaired in the early marker gene activation by
hrcC infiltration. The leaves from Col-0, Ws, fls2, and bak1 mutants (bak1-3,
bak1-4, and bak1-1) were inoculated with hrcC at 108 cfu/ml or with water con-
trol. Leaves were collected 6 hr after inoculation for RNA isolation and quanti-
tative RT-PCR analysis.
(B) The bak1mutants display reduced FRK1-LUC induction by many but not all
MAMPs. Protoplasts were transfected with the FRK1-LUC reporter and
treated with different MAMPs for 3 hr.
(C) AvrPto blocks FRK1-LUC induction by multiple MAMPs. Protoplasts were
transfected with FRK1-LUC with or without AvrPto. Transfected protoplasts
were incubated for 3 hr to express AvrPto before treatment with different
MAMPs for 3 hr. Different MAMPs in (B) and (C) are flg22, 10 nM; elf18,
10 nM; HrpZ, 100 nM; PGN, 50 mg/ml; chitin, 50 mg/ml; LPS, 50 mg/ml; and
NPP1, 20 nM. The data are shown as means ± standard errors from three
independent biological replicates. * indicates a significant difference with p <
0.05 when compared with data from control plants or treatment based on
the results of an unpaired Student’s t test.AvrPtoB, target BAK1 and block the ligand-induced formation
of MAMP-receptor complexes, thereby effectively impeding
multiple MAMP-signaling initiation. Significantly, natural levels
of AvrPto and AvrPtoB delivered by pathogenic bacteria are suf-
ficient to interfere with the endogenous MAMP-receptor com-
plex formation in plants. AvrPto and AvrPtoB have been long
studied as triggers to elicit potent immunity in tomato upon rec-
ognition by a serine/threonine kinase, Pto, in concert with the
NB-LRR protein Prf (Pedley and Martin, 2003). BAK1 as a newly
identified AvrPto/AvrPtoB target for bacterial virulence also con-
tains a cytosolic serine/threonine-kinase domain. It has been
suggested that effector targets in host cells for mediating viru-
lence or immunity might share similar molecular mechanisms
(Jones and Dangl, 2006). Surprisingly, our extensive compara-
tive mutagenesis and functional analysis reveal that the inter-
actions of BAK1 and Pto with AvrPto/AvrPtoB exhibit distinct
molecular features, indicating dynamic evolution in response
to pathogen challenges.
Multiple Roles of BAK1 in Plant Development,
Innate immunity, and Cell Death
BAK1 was first identified as a signaling partner of the BR recep-
tor BRI1, and it plays important roles in BR-mediated plant
development (Belkhadir et al., 2006; Li et al., 2002; Nam and
Li, 2002). Recently, BAK1 has emerged as an important player
in MAMP signaling where it associates with flagellin receptor
FLS2 upon flagellin treatment (Chinchilla et al., 2007; Heese
et al., 2007). There are several lines of evidence suggesting
that BAK1 may associate with multiple MAMP receptors. First,
bak1 mutants show reduced activation of early MAMP marker
genes triggered by nonpathogenic bacteria, DC3000 hrcC
(Figure 6A). The immune response induced by hrcC is likely de-
termined by multiple MAMPs. Second, BAK1 is required for host
responses resulting from recognition of several MAMPs, includ-
ing flagellin, EF-Tu, HrpZ, PGN, and LPS (Figure 6B). Third, bak1
mutants display altered disease susceptibility to several patho-
gens, including bacteria, necrotrophic fungi, and oomycetes
(Heese et al., 2007; Kemmerling et al., 2007). However, bak1mu-
tants have been shown to have normal binding capacity for BR to
BRI1 and flagellin to FLS2, respectively (Chinchilla et al., 2007;
Kinoshita et al., 2005). Although BAK1 is a partner of both BRI1
and FLS2, no overlapping responses are induced by BR and fla-
gellin. All these suggest that BAK1 is not involved in signal per-
ception but rather functions as an adaptor or partner of diverse
RLK complexes to regulate different downstream responses.
Interestingly, BAK1 also plays a negative role in the control of
plant programmed cell death (PCD) (He et al., 2007a; Kemmerl-
ing et al., 2007), consistent with eventual lethality of avrPto-
expressing transgenic plants and the transition of DC3000 to
a necrotrophic pathogen at the late-infection stage (Glazebrook,
2005). PCD is associated with both immunity and susceptibility
in plant-microbe interactions. Although bak1 mutants do not ex-
hibit spontaneous cell death, they develop spreading necrosis
upon pathogen infection, suggesting the role of BAK1 in the con-
trol of microbial-induced PCD (Kemmerling et al., 2007). This is
further supported by bak1 bkk1 double mutants, which display
spontaneous cell death, seedling lethality, and constitutive-
defense responses (He et al., 2007a). The BAK1-controlled
cell death appears to be BR independent since other BRCell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc. 23
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lated phenotype, and the application of BR in Arabidopsis bak1
mutants did not affect plant-cell death and disease resistance
(Kemmerling et al., 2007). However, BR has been implicated in
immunity in certain plant species as treatment of tobacco and
rice with BR induced a broad range of resistance to bacteria,
fungi, and virus (Nakashita et al., 2003). Thus, targeting BAK1
can serve multiple purposes to simultaneously modulate
MAMP-receptor complexes, BR signaling, and cell death for
the benefit of bacterial infection, life style, and fitness (Figure 7).
Complex Relationship between Bacterial
Effectors and Host Targets
Pathogenic bacteria deliver type III effectors into host cells to
promote pathogenicity. We have discovered that AvrPto and
AvrPtoB directly target BAK1—a shared-signaling partner but
not a PRR—and prevent stable-receptor signaling complex for-
mation and diverse downstream-signaling pathways during in-
fection. By targeting BAK1, AvrPto and AvrPtoB block multiple
MAMP-signaling and BR-signaling pathways, presumably
a more effective strategy than targeting individual receptors.
This is consistent with the BR-insensitive phenotype observed
in AvrPto-transgenic plants. From an evolutionary point of
view, it may be parsimonious for a pathogen effector to target
BAK1.
Recently, it has been proposed that AvrPto targets FLS2 and
EFR and blocks flg22 signaling (Xiang et al., 2008). However,
our extensive functional and protein-interaction analyses of
AvrPto and AvrPtoB mutants and deletions demonstrated that
the association of AvrPto/AvrPtoB with FLS2 is not correlated
with their suppression activity in MAMP signaling and only
occurs when all proteins are overexpressed. Importantly, the
same set of comprehensive analyses support the functional sig-
nificance of the interactions between AvrPto/AvrPtoB and BAK1
in vivo (Figures 1D, 2A, 2B, 3A, S4, S5, and S6). The association
of AvrPto with FLS2 or EFR is consistently much weaker than
that with BAK1, and AvrPto preferentially binds to BAK1 over
FLS2 in yeast and plant cells (Figures 1D and 2C). Our diverse
assays also define multiple BAK1 domains for the AvrPto-
BAK1 interaction while the kinase domain alone is not sufficient
Figure 7. A Model of Distinct AvrPto and AvrPtoB Actions via
Their Target Proteins in Controlling Plant Immunity, Develop-
ment, and Cell Death
AvrPto and AvrPtoB directly target Arabidopsis BAK1, a signaling
partner of multiple MAMP receptors and BR receptor BRI1, and
prevent stable receptor-signaling complex formation and diverse
downstream signaling triggered by different MAMPs and BR. BAK1,
as well as its closest homolog BKK1, also plays a negative role in
the control of plant cell death. AvrPto and AvrPtoB may also target
BAK1-independent receptor complexes or other unknown compo-
nents to intercept MAMP-signaling pathways. In tomato, AvrPto and
AvrPtoB are recognized by Pto kinase in concert with the NB-LRR
protein Prf to initiate effector-triggered immunity.
(Figure 4). It is possible that AvrPto may target multiple
RLKs when it is expressed at a high level. However, dur-
ing the natural plant-microbe interaction, the amount of
AvrPto delivered into host cells by bacteria would not ap-
pear to be sufficient to interact with many RLKs at relatively low
affinity to suppress signaling triggered by multiple MAMPs.
Emerging evidence indicates that bacterial effectors can have
multiple targets in their hosts. Besides BAK1, AvrPto and AvrP-
toB may also target BAK1-independent receptor complexes
(Figure 7) or other unknown components to intercept multiple
MAMP-signaling pathways. Apparently, AvrPto and AvrPtoB in-
teract with proteins closely related to BAK1, BKK1/SERK4, and
SERK5 (Figure S10), which may provide redundant functions
with BAK1 in MAMP signaling and BR signaling. Several type
III effectors possess enzymatic activities and could potentially
target many host proteins (Chisholm et al., 2005; Shan et al.,
2007). It is likely that bacterial effectors can target distinct host
pathways to promote pathogenicity, whereas plants may use
multiple host components to subdue their virulence.
Distinct Host Targets in Elicitation
and Suppression of Immunity
In tomato, the protein kinase Pto recognizes bacterial effector
AvrPto or AvrPtoB to initiate ETI in concert with the NB-LRR pro-
tein Prf (Pedley and Martin, 2003). It was postulated that in
tomato plants lacking Prf, Pto might be a virulence target of
AvrPto/AvrPtoB. However, these effectors are now known to ex-
ert their virulence activities in the absence of Pto in tomato and
Arabidopsis (He et al., 2006; Xiao et al., 2007). Analyses of
BAK1 and AvrPto mutations and AvrPtoB deletions in this study
further suggest that, at least for AvrPto and AvrPtoB, their dual
but opposite activities as virulence factors in disrupting MAMP
signaling and as determinants for ETI are mediated through dis-
tinct host targets and mechanisms, e.g., interfering with the
FLS2-BAK1 receptor-signaling complex and recognizing the
Pto-Prf immune sensor complex, respectively. Furthermore,
the molecular basis of AvrPto-BAK1 and AvrPto-Pto (Xing
et al., 2007) interactions appears to be distinct.
Based on modeling with the mammalian PKA inhibitor (PKI),
AvrPto was proposed to function as a kinase inhibitor of tomato
Pto kinase with a high affinity (Ki = 1 nM) (Grove et al., 1987; Xing
et al., 2007). Although AvrPto binds to Pto with a relatively high
affinity in vitro (Kd = 0.11 mM), 100-fold higher concentration of
AvrPto (11 mM) was required to inhibit 50% Pto-kinase activities24 Cell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc.
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potent than the established PKI (Grove et al., 1987). It is not clear
whether AvrPto delivered by bacteria into plant cells reaches
such high protein concentrations that were used for the in vitro
inhibitor assays. In our in vivo phosphorylation assay, AvrPto
did not affect the phosphorylation of its Arabidopsis virulence
target BAK1 (Figure S7B). As AvrPto delivered from bacteria
during infection is sufficient to interfere with MAMP signaling
(Figure 3C), the detailed molecular and biochemical action of
AvrPto and AvrPtoB on targeting receptor kinases requires fur-
ther characterization in vivo in a physiological context.
Our studies support the notion that distinct effector proteins
can share the same host targets, and also each effector protein
can manipulate multiple host factors. Potent and versatile type III
suppressors such as AvrPto and AvrPtoB could be used as valu-
able molecular probes to search for new receptors, receptor
partners, and signaling regulators for multiple MAMPs and to
elucidate the mechanisms important for plant-innate immunity
and bacterial pathogenicity. As exemplified by the AvrPto-
BAK1 interaction and a study on viral effector (Fontes et al.,
2004), it is possible that some animal pathogens have also
evolved effectors to target PRRs or their immediate-signaling
complexes to effectively intercept innate-immune signaling
near the MAMP perception step to promote pathogenicity. Fu-
ture studies will uncover the complex cellular networks involving
a plethora of host proteins and effectors derived from various
pathogens contributing to the dynamic and intimate relation-
ships in host and microbe interactions.
EXPERIMENTAL PROCEDURES
Plant Growth, Pathogen Assay, and Generation of Transgenic Plants
Wild-type (Col-0 and Ws) fls2 and bak1 mutant Arabidopsis plants were grown
in a growth chamber at 23C, 65% relative humidity, 75 mE light with a 12 hr
photoperiod for 30 days before protoplast isolation or bacterial inoculation.
To examine the open-cotyledon phenotype, DEX-inducible avrPto transgenic
bak1-3, bak1-4, and det2 mutant seedlings were grown at 23C for 7 days in
the dark with or without 10 mM DEX on 1/2 MS plates with 1% sucrose and
0.9% agar. The fls2 (Salk_141277) mutant is in the Col-0 background. The
bak1-1 mutant is in the Ws background, which does not have a functional
FLS2 (Li et al., 2002), and bak1-3 (Salk_034523) and bak1-4 (Salk_116202) mu-
tants are in the Col-0 background (Chinchilla et al., 2007; He et al., 2007a;
Heese et al., 2007; Kemmerling et al., 2007).
P. syringae tomatoDC3000, hrcC, andDavrPtoDavrPtoB strains were grown
overnight at 28C in the KB medium with appropriate antibiotics. Bacteria were
collected, washed, and diluted to the desired density with H2O. Arabidopsis
leaves were infiltrated with bacteria using a needleless syringe. The avrPto-
transgenic plants were generated by Agrobacterium-mediated transformation
with the avrPto construct under the control of a constitutive cauliflower mosaic
virus 35S promoter with an HA-epitope tag. DEX-inducible avrPto-transgenic
plants were reported previously (He et al., 2006). The DEX-inducible avrPto-
transgenic plants were crossed to the BAK1::BAK1-GFP transgenic plants
(Nam and Li, 2002). The transgenic plants carrying both avrPto-HA and
BAK1-GFP were confirmed by western blot.
MAMP Preparation
flg22 was synthesized according to the published sequence (Felix et al., 1999).
HrpZ and NPP1 were prepared as described (Fellbrich et al., 2002; Lee et al.,
2001). GST was used as a control of NPP1. PGN from Staphylococcus aureus
(Fluka Cat # 77140), chitin from crab shells (Cat # C9752), and LPS from Pseu-
domonas aeruginosa (Cat # L2012) were purchased from Sigma.Plasmid Constructs and Protoplast-Transient Assays
Bacterial or plant genes were amplified by PCR and introduced into a plant-ex-
pression vector with a HA-, FLAG-, or GFP-epitope tag at the C terminus. All ef-
fector constructs were reported previously (He et al., 2006).Arabidopsis genes
except EFR were PCR amplified from Col-0 cDNA and confirmed by DNA se-
quencing. Protoplast-transient assay was carried out as described (He et al.,
2006). For reporter assays, 50 ml protoplasts at a density of 2 3 105 /ml were
transfected with 10 mg plasmid DNA-expressing effectors and reporters. For
immunoprecipitation assays, 1 ml protoplasts were transfected with 200 mg
plasmid DNA-expressing receptor-like kinases and/or type III effectors.
RT-PCR Analysis
Total RNA was isolated from leaves or seedlings with TRIzol Reagent (Invitro-
gen). First strand cDNA was synthesized from 1 mg of total RNA with reverse
transcriptase. Real-time RT-PCR analysis was carried out with an iCycler iQ
real-time PCR-detection system using iQ SYBR green supermix (BIO-RAD).
UBQ10 was used as a control gene, and the expression of individual genes
was normalized to the expression of UBQ10.
Immunoprecipitation Assay
Proteins were prepared from 1 ml transfected protoplasts with 0.5 ml of extrac-
tion buffer (10 mM HEPES [pH 7.5], 100 mM NaCl, 1 mM EDTA, 10% glycerol,
0.5% Triton X-100, and a protease inhibitor cocktail from Roche). After being
vortexed vigorously for 30 s, the samples were centrifuged at 13,000 rpm for
10 min at 4C. The supernatant was incubated with prewashed anti-HA-aga-
rose or anti-FLAG-agarose beads for 3 hr at 4C with gentle shaking. The
beads were collected and washed four times with washing buffer (10 mM
HEPES [pH 7.5], 100 mM NaCl, 1 mM EDTA, 10% glycerol, 0.1% Triton
X-100, and a protease inhibitor cocktail) and once with 50 mM Tris-HCl (pH
7.5). Coimmunoprecipitated proteins were analyzed by western blot with an
anti-HA or anti-FLAG antibody. The protein bands with appropriate molecular
weights were shown.
To perform immunoprecipitation assay with seedlings, 12-day-old seedlings
carrying both the DEX-inducible avrPto and BAK1::BAK1-GFP transgenes
were treated with or without 1 mM flg22 for 5 min. Proteins from five seedlings
were extracted with 1 ml of extraction buffer by grinding. To detect the BAK1
and FLS2 association induced by bacteria, bacteria were first cultured at 28C
in the KB medium with appropriate antibiotics for overnight. Then, the bacteria
were transferred into the minimal medium containing 10 mM fructose (pH 6.0)
and cultured at room temperature for another 4 hr (Huynh et al., 1989). The
bacteria were collected and diluted at 53 108 cfu/ml with water, and hand in-
filtrated into 4-week-old BAK1::BAK1-GFP-transgenic plant leaves. Proteins
from eight leaves were extracted with 1.5 ml of extraction buffer. The samples
were centrifuged at 13,000 rpm for 10 min at 4C. The supernatant of each
sample was adjusted to the same concentration of protein and incubated
with an anti-GFP antibody for 2 hr at 4C with gentle shaking. The samples
were further incubated with protein-G-agarose for 2 hr and washed four times
with the washing buffer and once with 50 mM Tris-HCl (pH 7.5). Coimmunopre-
cipitated proteins were analyzed by western blot with an anti-FLS2 antibody
(Heese et al., 2007).
Yeast Assays
Mating-based split-ubiquitin system (mbSUS) was described by Obrdlik
et al., 2004. PCR products of BAK1, BRI1, and FLS2 were introduced into
pMetYCgate vector by in vivo cloning and transformed into the yeast AP4
strain. PCR products of avrPto, avrPtoS46P, and avrRpt2 were introduced
into pNXgate32-3HA vector by in vivo cloning and transformed into the yeast
AP5 strain. Yeast-diploid colonies were obtained after mating and selected on
the selection medium, and the specific protein-protein interaction was tested
by growing yeast on the synthetic minimal medium with or without 200 mM
methionine. The results were recorded 4 days after yeast grew at 28C on
the synthetic minimal medium with 200 mM methionine for stringent selection.
Yeast two-hybrid assay was performed with MATCHMAKER Two-Hybrid
System 3 from Clontech according to manufacturer’s handbook. AvrPto was
cloned into pGADT7 vector. Pto and the kinase domains of BAK1 (BAK1K)
and FLS2 (FLS2K) were cloned into pGBKT7 vector.
The primer sequences of constructs in yeast assays and protoplast transient
assays are listed in the Supplemental Data.Cell Host & Microbe 4, 17–27, July 17, 2008 ª2008 Elsevier Inc. 25
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